Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

5 Value Stocks In The Healthcare Sector

Author: Benzinga Insights | May 08, 2023 10:43am

What Defines a Value Stock?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

  1. Assertio Holdings (NASDAQ:ASRT) - P/E: 3.03
  2. Pfizer (NYSE:PFE) - P/E: 7.59
  3. AcelRx Pharmaceuticals (NASDAQ:ACRX) - P/E: 0.11
  4. Innoviva (NASDAQ:INVA) - P/E: 4.96
  5. Intercure (NASDAQ:INCR) - P/E: 8.38

Most recently, Assertio Holdings reported earnings per share at $0.32, whereas in Q3 earnings per share sat at $0.22. Pfizer saw an increase in earnings per share from 1.14 in Q4 to $1.23 now. Most recently, the company reported a dividend yield of 4.17%, which has increased by 1.0% from last quarter's yield of 3.17%.

AcelRx Pharmaceuticals saw a decrease in earnings per share from -0.94 in Q3 to $-1.0 now. Innoviva saw a decrease in earnings per share from 2.8 in Q3 to $-0.98 now. Intercure looks to be undervalued. It possesses an EPS of $0.05, which has not changed since last quarter (Q3).

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Posted In: ACRX ASRT INCR INVA PFE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist